March 23, 2015 9:51 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Monday, Bank of America analyst Ying Huang reiterated a Neutral rating and $179.00 price target on
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
(NASDAQ: AMGN).In the report, Bank of America noted, "The U.S. District Court for the Northern District of California has denied AMGN's request for an injunction against Novartis/Sandoz's launch of its Neupogen biosimilar, Zarxio. The court ruled that Sandoz's failure to provide AMGN with its BLA application does not provide reason for a preliminary injunction or any damages. AMGN has appealed the decision and both companies have agreed to an expedited review of the appeal. With the favorable ruling, Sandoz could launch Zarxio any day and has agreed to provide AMGN with 5 days' advanced notice before launching. Sandoz will disclose pricing at launch – this should be carefully monitored, as it could guide pricing of future biosimilars."Amgen closed on Friday at $169.11.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.